Plasticell Ltd:製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Plasticell Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7537)・商品コード:DATA904C7537
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:25
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Plasticell Ltd (Plasticell) is a biotechnology company that develops therapies derived from research using its combinatorial cell culture technology. The company offers therapeutic programs such as expansion of hematopoietic stem cells from bone marrow and cord blood, platelets and immune cells from induced pluripotent stem cells (iPSCs) and manufacturing of red blood cells. Its CombiCult technology allows testing for large numbers of cell culture variables to derive optimal laboratory protocols for any given outcome in cell biology such as cell expansion and differentiation, gene transduction, protein production, and provision of human cells for drug screening. The company collaborates with universities and industry partners to facilitate discovery and improve product manufacturing in the areas of cell therapy, gene therapy and drug discovery among others. Plasticell is headquartered in Stevenage, the UK.

Plasticell Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plasticell Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Plasticell Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Plasticell Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Plasticell Enters Into Licensing Agreement With JCR Pharma For CombiCult 11
Plasticell Enters into Partnership Agreement with Anthony Nolan 12
Plasticell Enters into Agreement with GlaxoSmithKline 13
Plasticell Enters into Agreement with Kings College London 14
Plasticell Enters into Research Agreement with Agency for Science, Technology and Research 15
Plasticell Enters into Research Agreement with Nanyang Technological University 16
Plasticell Enters into Agreement with CellSpring 17
Plasticell Enters into Research Agreement with Sphere Fluidics 18
Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement 19
Licensing Agreements 20
Plasticell Enters Into Licensing Agreement With EMD Millipore For Xeno-Free Osteogenic Medium 20
Equity Offering 21
Plasticell Raises USD1.6 Million in Private Placement of Shares 21
Plasticell Ltd – Key Competitors 22
Plasticell Ltd – Key Employees 23
Plasticell Ltd – Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Plasticell Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plasticell Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plasticell Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Plasticell Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Plasticell Enters Into Licensing Agreement With JCR Pharma For CombiCult 11
Plasticell Enters into Partnership Agreement with Anthony Nolan 12
Plasticell Enters into Agreement with GlaxoSmithKline 13
Plasticell Enters into Agreement with Kings College London 14
Plasticell Enters into Research Agreement with Agency for Science, Technology and Research 15
Plasticell Enters into Research Agreement with Nanyang Technological University 16
Plasticell Enters into Agreement with CellSpring 17
Plasticell Enters into Research Agreement with Sphere Fluidics 18
Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement 19
Plasticell Enters Into Licensing Agreement With EMD Millipore For Xeno-Free Osteogenic Medium 20
Plasticell Raises USD1.6 Million in Private Placement of Shares 21
Plasticell Ltd, Key Competitors 22
Plasticell Ltd, Key Employees 23

List of Figures
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plasticell Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Plasticell Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[Plasticell Ltd:製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C7537)販売に関する免責事項を必ずご確認ください。
★調査レポート[Plasticell Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆